Search research articles
Contact Us
Filters
Showing results (31-40 of 65) with videos related to
Page
of 7
Sort By:
International Journal of Cancer
|
May 4, 1999
Alteration of the daunorubicin-triggered sphingomyelin-ceramide pathway and apoptosis in MDR cells: influence of drug transport abnormalities
M G Côme, A Bettaieb, A Skladanowski, et al.
The Journal of Biological Chemistry
|
October 25, 1993
DNA topoisomerase II and casein kinase II associate in a molecular complex that is catalytically active
K Bojanowski, O Filhol, C Cochet, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 1, 1992
Time course of the distribution of morphine in brain regions and spinal cord after intravenous injection to spontaneously hypertensive and normotensive Wistar-Kyoto rats
H N Bhargava, V M Villar, N H Rahmani, et al.
Brain Research
|
April 2, 1993
Naltrexone-induced alterations of the distribution of morphine in brain regions and spinal cord of the rat
H N Bhargava, A K Larsen, N H Rahmani, et al.
Artificial Organs
|
May 1, 1984
Effect of extracorporeal enzymatic deheparinization on formed blood components
A K Larsen, R J Linhardt, D Tapper, et al.
Brain Research
|
March 14, 1997
In vivo and in vitro experiments show that betaxolol is a retinal neuroprotective agent
N N Osborne, C Cazevieille, A L Carvalho, et al.
The Journal of Biological Chemistry
|
August 16, 2000
Mitotic phosphorylation of DNA topoisomerase II alpha by protein kinase CK2 creates the MPM-2 phosphoepitope on Ser-1469
A E Escargueil, S Y Plisov, O Filhol, et al.
Biochemistry
|
March 21, 1995
Changes of self-association, secondary structure, and biological activity properties of topoisomerase II under varying salt conditions
S Lamhasni, A K Larsen, M Barray, et al.
The Journal of Biological Chemistry
|
January 25, 1989
Resistance of heparinase-derived heparin fragments to biotransformation
A K Larsen, K G Rice, R J Linhardt, et al.
Journal of Cellular Biochemistry
|
April 21, 1998
DNA topoisomerase II can drive changes in higher order chromosome architecture without enzymatically modifying DNA
K Bojanowski, A J Maniotis, S Plisov, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 65) with videos related to
Sort By:
Page
of 7
International Journal of Cancer
|
May 4, 1999
Alteration of the daunorubicin-triggered sphingomyelin-ceramide pathway and apoptosis in MDR cells: influence of drug transport abnormalities
M G Côme, A Bettaieb, A Skladanowski, et al.
The Journal of Biological Chemistry
|
October 25, 1993
DNA topoisomerase II and casein kinase II associate in a molecular complex that is catalytically active
K Bojanowski, O Filhol, C Cochet, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 1, 1992
Time course of the distribution of morphine in brain regions and spinal cord after intravenous injection to spontaneously hypertensive and normotensive Wistar-Kyoto rats
H N Bhargava, V M Villar, N H Rahmani, et al.
Brain Research
|
April 2, 1993
Naltrexone-induced alterations of the distribution of morphine in brain regions and spinal cord of the rat
H N Bhargava, A K Larsen, N H Rahmani, et al.
Artificial Organs
|
May 1, 1984
Effect of extracorporeal enzymatic deheparinization on formed blood components
A K Larsen, R J Linhardt, D Tapper, et al.
Brain Research
|
March 14, 1997
In vivo and in vitro experiments show that betaxolol is a retinal neuroprotective agent
N N Osborne, C Cazevieille, A L Carvalho, et al.
The Journal of Biological Chemistry
|
August 16, 2000
Mitotic phosphorylation of DNA topoisomerase II alpha by protein kinase CK2 creates the MPM-2 phosphoepitope on Ser-1469
A E Escargueil, S Y Plisov, O Filhol, et al.
Biochemistry
|
March 21, 1995
Changes of self-association, secondary structure, and biological activity properties of topoisomerase II under varying salt conditions
S Lamhasni, A K Larsen, M Barray, et al.
The Journal of Biological Chemistry
|
January 25, 1989
Resistance of heparinase-derived heparin fragments to biotransformation
A K Larsen, K G Rice, R J Linhardt, et al.
Journal of Cellular Biochemistry
|
April 21, 1998
DNA topoisomerase II can drive changes in higher order chromosome architecture without enzymatically modifying DNA
K Bojanowski, A J Maniotis, S Plisov, et al.
Page
of 7